Kimberly-Clark Corporation
KMB Consumer Defensive Household & Personal Products
In the quarter to June 2026, revenue was flat, EPS fell 32.0%, free cash flow fell 4.79% and total debt fell 10.0%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.
Follow KMB
Kimberly-Clark Corporation (KMB) EPS (diluted)
Kimberly-Clark Corporation's EPS (diluted) for fiscal 2025 was $6.07, down 19.6% from $7.55 in fiscal 2024. Over the twelve months to 30 June 2026 it was $5.88. Over the past ten years it has ranged from $2.77 (fiscal 2015) to $7.55 (fiscal 2024); the current reading is higher than 64% of that period. Kimberly-Clark Corporation ranks 2nd of 27 Household & Personal Products companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $6.07 | (19.60%) |
| FY2024 | $7.55 | 44.91% |
| FY2023 | $5.21 | (8.92%) |
| FY2022 | $5.72 | 6.92% |
| FY2021 | $5.35 | (22.13%) |
| FY2020 | $6.87 | 10.10% |
| FY2019 | $6.24 | 54.84% |
| FY2018 | $4.03 | (37.03%) |
| FY2017 | $6.40 | 6.84% |
| FY2016 | $5.99 | 116.25% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $1.04 | (48.00%) |
| Mar 2026 | $2.00 | 33.33% |
| Dec 2025 | $1.50 | 11.94% |
| Sep 2025 | $1.34 | (12.42%) |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| KMB Kimberly-Clark Corporation | $5.88 |
| IPAR Interparfums, Inc. compare | $5.23 |
| CLX The Clorox Company compare | $4.82 |
| CHD Church & Dwight Co., Inc. compare | $3.11 |
| CL Colgate-Palmolive Company compare | $2.52 |
| ELF e.l.f. Beauty compare | $1.00 |
| KVUE Kenvue Inc. compare | $0.87 |
| EL The Estee Lauder Companies Inc. compare | $0.49 |
| UL Unilever PLC compare | — |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on KMB
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement